CATALYST PHARMACEUTICALS, INC. - Director's Dealing 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-08-09

Reporting Person: Del Carmen Jeffrey (Chief Commercial Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-09	Common stock, par value $0.001 per share	S	6058	$18.44	Disposed	12369	Direct
2024-08-09	Common stock, par value $0.001 per share	M	30000	$2.86	Acquired	42369	Direct
2024-08-09	Common stock, par value $0.001 per share	S	30000	$18.42	Disposed	12369	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-09	Options to purchase common stock	$2.86	M	30000	Disposed	2025-08-06	Common Stock (30000)	Direct

F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.

F2: Shares were sold in various lots from $18.33 to $18.48 per share. The price listed represents a weighted average price for the shares sold.

F3: Shares vested in five annual tranches beginning on August 6, 2019.